Computer-Aided Drug Resistance Calculator (CADRC) Initiative:
CADRC-Initiative.org
The CADRC Initiative is a Dallas‑based bioinformatics institution that houses (will handle the development of) the patented technology, the Computer-Aided Drug Resistance Calculator (US11227669B2). Felbex provides the administrative and organizational foundation that supports these scientific efforts, while ownership of the underlying intellectual property remains with Norbert Nwankwo and Ngozika Njoku, the current recorded assignees at the United States Patent and Trademark Office (USPTO). Our works integrate computational modeling, digital signal analysis, stepwise reasoning to understand and predict drug resistance and other bio-mechanisms.
In a challenge organized by the NIH, DHHS and BARDA, and managed by the CCC Innovation Center, we presented a digital signal processing-based algorithm that will digitize genotypic characteristics encoded in the protein targets of medications, process and transform them back to the phenotypic features (drug resistance) using the amino acids involved. The drug resistance is instantly and numerically delivered to the Physicians to assist them in making quick and informed decisions on the best medication(s) for the patients.
We proposed that the algorithm will be centrally located for quality control, monitoring and upgrade and update while the health service providers will be provided with internet-enable access (computers, phones, etc) to retrieve the calculated resistance.
This is the stage we are. We are looking forward to establishing the Central Algorithm.
Norbert Nwankwo PhD, inventor/founder.
We intend to communicate research information on DSP-based investigations of biological functionalities and mechanisms via the “Get Started” below. We will let the public know whenever we have an update this section.
WE ARE YET TO LAUNCH THE DEVICE.
AFTER THEN YOU CAN CARRY OUT YOUR TEST.
All content of this site is for research and informational use, and is provided free of charge. This site is not created for any form of transaction. Our device will be launched in another site when ready.OUR MISSION
Our mission is to make biological computation transparent, reproducible, and accessible.
We develop digital signal (FFT)–based methods that reveal how biological features emerge from sequence data, supporting clear understanding of biological mechanisms such as drug resistance, viral translation, etc.
We maintain source‑verified and source‑protected workflows that ensure every computational step is traceable, interpretable, and reproducible.
WE ARE YET TO LAUNCH THE DEVICE.
AFTER THEN, YOU CAN CARRY OUT YOUR TEST.
All content of this site is for research and informational use, and is free of charge. This site is not created for any form of transaction. Our Device will be launched in another site when ready.